Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Health and Happiness (H&H) International Holdings ( (HK:1112) ) has issued an update.
Health and Happiness (H&H) International Holdings reported a 34.4% year-on-year rise in first-quarter 2026 revenue to RMB4.26 billion, with high-margin nutritional supplements contributing nearly 60% of sales. Growth was broad-based across adult, baby and pet segments, aided by Chinese New Year seasonality and stronger demand for Biostime infant milk formulas in mainland China.
The Baby Nutrition and Care business led performance with a 60.9% increase, including a 74.4% surge in infant formula sales in China, while Adult Nutrition and Care grew 26.3% and Pet Nutrition and Care achieved modest gains but faster growth in premium pet supplements such as Zesty Paws. The group also continued to deleverage, cutting gross debt by over RMB300 million by voluntarily prepaying more than RMB500 million of its U.S. dollar term loan, supported by stronger internal liquidity and cheaper renminbi borrowing, which strengthens its balance sheet and financial flexibility.
The most recent analyst rating on (HK:1112) stock is a Buy with a HK$15.80 price target. To see the full list of analyst forecasts on Health and Happiness (H&H) International Holdings stock, see the HK:1112 Stock Forecast page.
More about Health and Happiness (H&H) International Holdings
Health and Happiness (H&H) International Holdings is a Hong Kong–listed health and wellness company focused on baby nutrition and care, adult nutrition and care, and pet nutrition and care. Its portfolio includes infant milk formula, paediatric probiotics, vitamins and supplements, and premium pet supplements, with significant exposure to the Chinese mainland, Australia-New Zealand and selected expansion markets.
Average Trading Volume: 2,015,862
Technical Sentiment Signal: Buy
Current Market Cap: HK$8.83B
For a thorough assessment of 1112 stock, go to TipRanks’ Stock Analysis page.